The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.895
Bid: 0.87
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.05 (5.747%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.895
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategic Initiatives

7 Nov 2012 07:00

RNS Number : 4925Q
J.P. Morgan Private Equity Ltd
07 November 2012
 

JPEL ANNOUNCES STRATEGIC INITIATIVES

 

·; Reposition JPEL portfolio

o Coupled with available capital from net distributions from JPEL's existing portfolio, explore sale of pre-credit crisis assets in secondary market to invest in growth opportunities

o Create a more transparent and concentrated portfolio

o Existing deal flow and return expectations are very attractive

·; Continue to improve capital structure

o Retire 2013 Zero Dividend Preference Shares in April 2013

o Aim to reduce JPEL debt by 2015 while improving interest costs

·; Provide liquidity for holders of US$ Equity Shares

o It is JPEL's current policy to return 50% of portfolio distributions, net of capital calls, operating expenses and any near term payment obligations, to shareholders1

o To that end, JPEL will seek to purchase up to $20 million of US$ Equity Shares, or approximately 9% of shares outstanding through a coordinated share repurchase programme on 14 November 2012 at up to a 35% discount to prevailing NAV dated 30 September 2012. Any such purchases will be accretive to the NAV of the remaining US$ Equity Shares

o Continue to look to purchase US$ Equity Shares through a variety of programmes

 

* * *

 

GUERNSEY, 7 NOVEMBER 2012

 

Today, J.P. Morgan Private Equity Limited ("JPEL" or the "Company") is pleased to announce a series of strategic initiatives that the Board believes demonstrates its continued commitment to shareholders.

 

"Since inception, implementing JPEL's core strategy has involved investing in seasoned private equity assets that are repositioned approximately every 36 months by redeploying net distributions in new private equity investments and returning substantial levels of capital to US$ Equity Shareholders through a variety of methods." said Trevor Ash, JPEL's Chairman. "In the years following the credit crisis, distribution levels from the JPEL portfolio, although greatly improved in recent months, was limited. As a result, the ability of the Company to reposition its portfolio as well as the quantum and frequency of distributions to US$ Equity Shareholders was reduced."

 

"Today, we are implementing a more aggressive series of strategic initiatives to enable the Company to once again actively reposition its portfolio and return larger amounts of capital to US$ Equity Shareholders while maintaining strong cover for ZDP holders. As a first step, JPEL will seek to repurchase up to $20 million of US$ Equity Shares through a coordinated share repurchase programme." added Mr. Ash.

 

The Company's strategic initiatives are highlighted in greater detail below:

 

Actively Reposition JPEL Portfolio

 

JPEL is currently exploring the possibility of selling certain portfolio investments in the secondary market and aggregating such potential proceeds with available capital from net distributions in order to reposition the Company's portfolio. In particular, JPEL will seek to reposition its portfolio towards growth-oriented investments in a more concentrated portfolio that will allow for more specific transparency to shareholders.

 

Since inception, JPEL has sought to reposition its portfolio by redeploying net distributions in new private equity investments. In the years following the credit crisis, distribution activity from the JPEL portfolio, although greatly improved in recent months, was limited. As a result, the Company was not able to reposition its portfolio as aggressively as had been the case historically. Through strategic sales of non-core assets, JPEL will be in a strong position to take advantage of more attractive opportunities in the secondary private equity market. Notably, the Company's investment performance for assets purchased during or subsequent to the credit crisis has been strong and any asset sales will enable JPEL to continue to repopulate its portfolio with such higher-quality assets.

 

Continue to Improve Capital Structure

 

JPEL will seek to continue to improve its capital structure and lower overall gearing over the next three years. Specifically, JPEL is seeking to rationalise its capital structure through three key initiatives:

·; Increase NAV by repositioning the portfolio towards a more concentrated portfolio of growth oriented assets as noted above;

·; Repay the 2013 ZDP Shares in April 2013 and 2015 ZDP Shares in October 2015 using a combination of capital available through the Company's lower cost, more flexible bank facility as well as through net distribution and asset sale proceeds; and

·; Pay down bank facility borrowings over time using a portion of net cash flows from distributions and asset sales

 

Continue to Support US$ Equity Shares and Return Capital to Investors

 

On 14 November 2012 JPEL plans to commence a coordinated share repurchase programme, managed by JPMorgan Cazenove, to purchase up to $20 million of US$ Equity Shares outstanding at up to a 35% discount to prevailing NAV dated 30 September 2012. The price of the US$ Equity Shares repurchased by JPEL will be subject to satisfaction of the limits imposed at the Company's recent General Meeting that it must not exceed the higher of (a) 105 per cent. of the average market values for a US$ Equity Shares taken from the Official List of the UK Listing Authority for the five Business Days immediately preceding 14 November 2012 and, (b) the higher of the last independent trade and the highest current independent bid price on the trading venues where the purchase is carried out. This coordinated share repurchase programme will be accretive to the NAV of the remaining US$ Equity Shares.

 

Interested buyers or sellers of the Company's shares should contact J.P. Morgan Cazenove on or before 14 November 2012. The exact number of US$ Equity Shares to be repurchased by the Company, and the pricing of those Shares, will be determined following a book-build programme coordinated by J.P. Morgan Cazenove. Accordingly, the number of US$ Equity Shares and the value of such shares repurchased by the Company may be less than the Company's limit of $20 million. Any shortfall may be utilised by the Company, on terms decided by the Company, in making future purchases of US$ Equity Shares. J.P. Morgan Cazenove will seek to match sellers pursuant to the Company's share repurchase programme to natural buying interest at the same price.

 

In addition, JPEL will continue to look to purchase US$ Equity Shares through a variety of programmes. Since inception, JPEL has returned capital to investors through the operation of its tender facility and through open market share repurchases and has returned over $153 million to shareholders through such mechanisms. Moreover, since August 2011, JPEL has returned approximately 6.2% of the weighted average shares outstanding during fiscal year 2012 through a mix of share repurchases and a formal tender offer. Assuming completion of the coordinated share repurchase programme, JPEL will have repurchased approximately 15% of the weighted average US$ Equity Shares outstanding during fiscal year 2012.

 

This communication does not constitute an offer or invitation or solicitation to make an offer by or on behalf of the Company or any of its affiliates, directors, officers, employees or shareholders to buy, sell or enter into an agreement for the sale or purchase of shares or any of the businesses or assets described herein.

 

This communication is not and should not be taken as constituting the giving of investment advice by the Company or its managers to any recipient.

 

Past performance is not a guide to future performance and the value of investments and the income derived from those investments can go down as well as up. Future returns are not guaranteed and a total loss of principal may occur.

 

Recipients of this communication are recommended to seek their own independent legal, tax, financial and other advice and should rely solely on their own judgment, review and analysis in evaluating the Company, its business and its affairs.

 

This document includes statements that are, or may be deemed to be, "forward-looking statements". In some cases, these forward-looking statements can be identified by the use of forward-looking terminology, including the terms "targets", "believes", "estimates", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance. The Company's actual performance, results of operations, internal rate of return, financial condition, liquidity, distributions to shareholders and the development of its financing strategies may differ materially from the impression created by the forward-looking statements contained in this document.

 

1. Subject to applicable legal, corporate and regulatory restrictions. Shareholders should not expect that they will necessarily be able to realise, within a period which they would otherwise regard as reasonable, their investment in the Company, nor can they be certain that they will be able to realise their investment on a basis that necessarily reflects the value of the underlying investments held by the Company.

 

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPEZ, JPZZ, JPSZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market. On 17 August 2009, JPEL issued warrants free of subscription cost to shareholders on record. The warrants are publicly traded on the London Stock Exchange under the symbol "JPWW."

 

END

* * *

 

For further information please contact:

 

J.P. Morgan Private Equity Limited

Troy Duncan / Greg Getschow

Troy.Duncan@jpmorgan.com / Gregory.Getschow@jpmorgan.com

 

Rosemary DeRise / Samantha Ladd

+1 212 648 2980 / +1 212 648 2982

Rosemary.DeRise@jpmorgan.com / Samantha.Ladd@jpmorgan.com

 

Peregrine Communications

Anthony Payne / Max Hilton

+44 203 178 6869

anthony.payne@peregrinecommunications.com / max.hilton@peregrinecommunications.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGGBUGUPPGRQ
Date   Source Headline
23rd Apr 20245:18 pmRNSDirector Declaration
15th Mar 20246:15 pmRNSNet Asset Value - December 2023
15th Mar 20246:03 pmRNSHalf-year Report - December 2023
15th Mar 20243:50 pmRNSHalf-year Report - 2023
6th Dec 20235:36 pmRNSDirector Declaration
6th Dec 20235:33 pmRNSAGM RESULTS 2023
9th Nov 202311:56 amRNS2023 AGM CIRCULAR
8th Nov 20237:00 amRNSCompletion of Twelfth Mandatory Redemption
24th Oct 20237:00 amRNSTwelfth Mandatory Redemption & Shareholder Update
20th Oct 202310:28 amRNSNet Asset Value - September 2023
21st Sep 20235:33 pmRNSNet Asset Value(s) - June 2023
21st Jun 20233:36 pmRNSDirectorate Change
12th May 20231:46 pmRNSNet Asset Value(s) - March 2023
28th Mar 20233:32 pmRNSHalf-year Report - 31 December 2022
14th Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 202311:05 amRNSSecond Price Monitoring Extn
14th Mar 202311:00 amRNSPrice Monitoring Extension
14th Mar 20239:05 amRNSSecond Price Monitoring Extn
14th Mar 20239:00 amRNSPrice Monitoring Extension
24th Feb 20234:22 pmRNSNet Asset Value(s) - December 2022
13th Feb 20234:51 pmRNSDirector Declaration
22nd Dec 20227:00 amRNSCompletion of Eleventh Mandatory Redemption
14th Dec 20227:00 amRNSELEVENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE
13th Dec 20225:09 pmRNSDirectorate Change
29th Nov 20224:33 pmRNSAGM Results 2022
9th Nov 20224:11 pmRNS2022 AGM CIRCULAR
27th Oct 20226:26 pmRNSNet Asset Value - September 2022
23rd Sep 20224:54 pmRNSAnnual Financial Report - 30 June 2022
13th Sep 20223:03 pmRNSNet Asset Value(s) - June 2022
13th Jul 202211:36 amRNSNet Asset Value(s) - May 2022
6th Jul 20224:26 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSUpdate to Shareholders
23rd Jun 20225:10 pmRNSNet Asset Value(s) - April 2022
17th May 20227:00 amRNSNet Asset Value(s) - March 2022
11th May 202211:27 amRNSNet Asset Value - February 2022
6th May 20227:00 amRNSNet Asset Value - January 2022
5th May 20225:39 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSPortfolio Update
11th Apr 202212:34 pmRNSCompletion of Tenth Mandatory Redemption
4th Apr 20227:00 amRNSTenth Mandatory Redemption
17th Mar 20225:35 pmRNSHalf-year Report - 31 December 2021
7th Mar 20229:44 amRNSNet Asset Value - December 2021
19th Jan 20221:47 pmRNSNet Asset Value - November 2021
22nd Dec 20214:24 pmRNSNet Asset Value - October 2021
23rd Nov 20212:13 pmRNSAGM Results 2021
16th Nov 20214:42 pmRNSNet Asset Value - September 2021
3rd Nov 202112:29 pmRNSNet Asset Value - August 2021
2nd Nov 20211:49 pmRNS2021 AGM CIRCULAR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.